Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?

Aktas, H; Ertugrul, G

Aktas, H; Ertugrul, G.

Aktas H; Department of Dermatology, Karabuk University Faculty of Medicine, Karabuk, Turkey.
Ertugrul G; Department of Dermatology, Karabuk University Faculty of Medicine, Karabuk, Turkey.

Clin Exp Dermatol ; 47(1): 143-144, 2022 01.

Article in English | MEDLINE | ID: covidwho-1301464

Subject(s)

BNT162 Vaccine/adverse effects; Colitis, Ulcerative/complications; Vitiligo/etiology; COVID-19/prevention & control; Humans; Immunosuppressive Agents/therapeutic use; Male; Middle Aged; Tacrolimus/therapeutic use; Vitiligo/diagnosis; Vitiligo/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / Colitis, Ulcerative / BNT162 Vaccine Type of study: Case report / Diagnostic study Topics: Long Covid / Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Clin Exp Dermatol Year: 2022 Document Type: Article Affiliation country: Ced.14842

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google